3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 2
2
Phase 4
1
Status
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Breast Neoplasms
10
Prostatic Neoplasms
7
Neoplasms
6
Multiple Myeloma
6
Leukemia, Myeloid, Acute
4
Neoplasm Metastasis
3
Leiomyoma
3
Hematologic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Melanoma
2
Lung Neoplasms
2
Glioma
2
Colorectal Neoplasms
2
Carcinoma, Renal Cell
2
Vomiting
1
Venous Thromboembolism
1
Tumor Lysis Syndrome
1
Tuberous Sclerosis
1
Thyroid Neoplasms
1
Thyroid Diseases
1
Thoracic Neoplasms
1
Thalassemia
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Substitutes
1
Skin Neoplasms
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Pulmonary Embolism
1
Primary Myelofibrosis
1
Interventions
tocilizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Cytokine Release Syndrome
×
30 days
×
Clear all
NCT07609940
2026-05-27
POPLIN
Regeneron Pharmaceuticals
Phase 4
Not yet recruiting
30 enrolled